Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Natanson

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Biologics : Targets & Therapy|September 24, 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studiesLaith Altaweel, Daniel Sweeney, Xizhong Cui, et al.
The Journal of Trauma|April 13, 2005
Novel therapies for sepsis: a reviewKatherine J Deans, Michael Haley, Charles Natanson, et al.
JAMA|April 30, 2008
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysisCharles Natanson, Steven J Kern, Peter Lurie, et al.
Annals of Internal Medicine|July 9, 2004
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dosePeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|December 16, 2004
Substantiating the concerns about recombinant human activated protein C use in sepsisKatherine J Deans, Peter C Minneci, Steven M Banks, et al.
Annals of Internal Medicine|August 6, 2008
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?Denise A Gonzales, Robert A Star, Steven J Kern, et al.
Annals of Internal Medicine|February 21, 2018
Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1): A Systematic ReviewDominique J Pepper, Dharmvir Jaswal, Junfeng Sun, et al.
Annals of Internal Medicine|November 3, 2004
Corticosteroids for septic shockPeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|February 6, 2004
Should we continue to target the platelet-activating factor pathway in septic patients?Peter C Minneci, Katherine J Deans, Steven M Banks, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Biologics : Targets & Therapy|September 24, 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studiesLaith Altaweel, Daniel Sweeney, Xizhong Cui, et al.
The Journal of Trauma|April 13, 2005
Novel therapies for sepsis: a reviewKatherine J Deans, Michael Haley, Charles Natanson, et al.
JAMA|April 30, 2008
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysisCharles Natanson, Steven J Kern, Peter Lurie, et al.
Annals of Internal Medicine|July 9, 2004
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dosePeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|December 16, 2004
Substantiating the concerns about recombinant human activated protein C use in sepsisKatherine J Deans, Peter C Minneci, Steven M Banks, et al.
Annals of Internal Medicine|August 6, 2008
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?Denise A Gonzales, Robert A Star, Steven J Kern, et al.
Annals of Internal Medicine|February 21, 2018
Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1): A Systematic ReviewDominique J Pepper, Dharmvir Jaswal, Junfeng Sun, et al.
Annals of Internal Medicine|November 3, 2004
Corticosteroids for septic shockPeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Critical Care Medicine|February 6, 2004
Should we continue to target the platelet-activating factor pathway in septic patients?Peter C Minneci, Katherine J Deans, Steven M Banks, et al.
Pageof 12